![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Inflammatory Bowel Diseases |
|
Free Subscription
3 Aliment Pharmacol Ther |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Inflammatory Bowel Diseases is free of charge.
Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical
Advantage After Colectomy in Colonic Crohn's Disease. Authors' Reply.
Aliment Pharmacol Ther. 2026 May 12. doi: 10.1111/apt.70715.
PubMed
Editorial: Inflammatory Bowel Disease Care Pathways-Improving Quality, but Not at
Increased Cost.
Aliment Pharmacol Ther. 2026 May 11. doi: 10.1111/apt.70726.
PubMed
Review Article: TL1A Inhibitors in IBD - Mechanistic Rationale and Clinical
Evidence.
Aliment Pharmacol Ther. 2026;63:1458-1473.
PubMed
Abstract available
Hepatitis E virus seroprevalence and infection status among patients with
inflammatory bowel disease undergoing advanced therapy: a prospective
single-center observational study.
BMC Gastroenterol. 2026 May 12. doi: 10.1186/s12876-026-04907.
PubMed
Abstract available
Mapping the evolution of inflammatory bowel disease care in Brazil: a comparison
of cross-sectional surveys from 2017 and 2023.
BMC Gastroenterol. 2026 May 12. doi: 10.1186/s12876-026-04903.
PubMed
Abstract available
Efficacy and safety of dual biologics or combination therapy with JAK inhibitors
in refractory inflammatory bowel disease: a retrospective single-center
real-world study from China.
BMC Gastroenterol. 2026 May 11. doi: 10.1186/s12876-026-04905.
PubMed
Abstract available
Specific alterations in the gut microbiome and metabolome across disease
locations of Crohn's disease: a systematic review.
BMC Gastroenterol. 2026 May 11. doi: 10.1186/s12876-026-04898.
PubMed
Abstract available
A gut vascular barrier damage-based scoring system predicts postoperative
outcomes in Crohn's disease.
BMC Gastroenterol. 2026 May 8. doi: 10.1186/s12876-026-04892.
PubMed
Abstract available
SOCS1 Haploinsufficiency in a Patient with Granulomatous Interstitial Lung
Disease and Inflammatory Bowel Disease-like Disease.
Clin Exp Immunol. 2026 May 8:uxag023. doi: 10.1093.
PubMed
Abstract available
Clin Res Hepatol Gastroenterol
Comments on "incidence and neoplastic risk associated with colonic stricture in
paediatric-onset Crohn's disease: A population-based study".
Clin Res Hepatol Gastroenterol. 2026;50:102840.
PubMed
EFFECTIVENESS OF RISANKIZUMAB AFTER USTEKINUMAB FAILURE IN CROHN'S DISEASE: A
MULTICENTER RETROSPECTIVE COHORT STUDY.
Gastroenterology. 2026 May 8:S0016-5085(26)06830.
PubMed
Disease phenotype affects treatment of late-onset inflammatory bowel disease:
Analysis of a large UK cohort.
Inflamm Bowel Dis. 2026 May 8:izag072. doi: 10.1093.
PubMed
Abstract available
Soluble transferrin receptor as a reliable inflammation-independent marker of
iron deficiency in Crohn's disease and ulcerative colitis.
Inflamm Bowel Dis. 2026 May 9:izag057. doi: 10.1093.
PubMed
Abstract available
Authors' response to letter to editor-silencing GATA3: DNAzymes enter the
therapeutic landscape of ulcerative colitis.
Inflamm Bowel Dis. 2026 May 11:izag077. doi: 10.1093.
PubMed
Targeting the transcription factor GATA3 by the DNAzyme formulation SB012 in
patients with moderately-to-severely active ulcerative colitis: a multicenter,
randomized, placebo-controlled, phase 2a induction trial.
Inflamm Bowel Dis. 2026 May 12:izag046. doi: 10.1093.
PubMed
Abstract available
Correction to: Early Top-Down Treatment With Biologics Improves the Rates of
Transmural Remission in Crohn's Disease-A Risk-Adjusted Propensity Score Matched
Analysis.
Inflamm Bowel Dis. 2026 May 13:izag084. doi: 10.1093.
PubMed
The missing evidence: Stricturing Crohn's disease in clinical trials, a
systematic review.
Inflamm Bowel Dis. 2026 May 14:izag079. doi: 10.1093.
PubMed
Abstract available
Multi-omics-based machine learning model predicts response and guides treatment
in Crohn's disease: a case study in nutritional therapy-response to editorial.
Inflamm Bowel Dis. 2026 May 14:izag087. doi: 10.1093.
PubMed
Repeated opioid use during pregnancy in women with inflammatory bowel disease:
prevalence and impact on birth outcomes in Denmark.
J Crohns Colitis. 2026;20:jjag046.
PubMed
Abstract available
Bayesian prior elicitation on the efficacy of medical therapies in perianal
fistulizing Crohn's disease.
J Crohns Colitis. 2026;20:jjag061.
PubMed
Abstract available
Mirikizumab is associated with rapid and sustained improvements in novel measures
of bowel urgency in moderately-to-severely active ulcerative colitis: 28-week
results from the LUCENT-URGE trial.
J Crohns Colitis. 2026;20:jjag049.
PubMed
Abstract available
Crohn's Disease Activity Index in the era of obesity: time to abandon it?
J Crohns Colitis. 2026;20:jjag050.
PubMed
Abstract available
Comparative risk of serious infection in patients with ulcerative colitis treated
with JAK inhibitors.
J Crohns Colitis. 2026;20:jjag053.
PubMed
Abstract available
Intestinal ultrasound reliably predicts fecal loading in patients with ulcerative
colitis.
J Crohns Colitis. 2026;20:jjag052.
PubMed
Abstract available
Beyond the bowel: three rare complications of upadacitinib therapy in
inflammatory bowel disease.
J Crohns Colitis. 2026;20:jjag058.
PubMed
Abstract available
Hyperbaric oxygen therapy alters bowel perfusion and improves outcomes in
patients with treatment-refractory ulcerative colitis: a prospective pilot trial.
J Crohns Colitis. 2026;20:jjag065.
PubMed
Abstract available
Antibiotic Utilization for Perianal Fistulizing Complications Among Young
Patients with Crohn's Disease.
J Pediatr. 2026 May 7:115142. doi: 10.1016/j.jpeds.2026.115142.
PubMed
Abstract available
Breaking the therapeutic ceiling in inflammatory bowel disease: myth or reality?
Lancet Gastroenterol Hepatol. 2026 May 14:S2468-1253(26)00085.
PubMed
Abstract available
Appendicectomy: a disease-modifying treatment for ulcerative colitis? - Authors'
reply.
Lancet Gastroenterol Hepatol. 2026;11:447.
PubMed
Appendicectomy: a disease-modifying treatment for ulcerative colitis?
Lancet Gastroenterol Hepatol. 2026;11:446.
PubMed
Predictive value of iron deficiency anaemia on the one-year disease course in
inflammatory bowel disease patients in clinical and biochemical remission.
Scand J Gastroenterol. 2026 May 11:1-9. doi: 10.1080/00365521.2026.2651163.
PubMed
Abstract available
Incidence and prevalence of inflammatory Bowel disease in China: a regional
population-based study from 2020 to 2022.
Scand J Gastroenterol. 2026 May 11:1-9. doi: 10.1080/00365521.2026.2668430.
PubMed
Abstract available
When Behcet Mimics Crohn's disease: A Diagnostic Challenge.
Z Gastroenterol. 2026 May 12. doi: 10.1055/a-2857-7832.
PubMed
Abstract available
Thank you for your interest in scientific medicine.